21 CFR 862.1685
§ 862.1685 Thyroxine-binding globulin test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1685, § 862.1685 Thyroxine-binding globulin test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89187
- Permanent ID
ys:prov:89187@1- SHA-256
9d3c2112bf93f2b7f7ce6b150ac2e39ce5b64e29ca6084f347fae429ef1003f3
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A thyroxine-binding globulin test system is a device intended to measure thyroxine (thyroid)-binding globulin (TBG), a plasma protein which binds thyroxine, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases.
(b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.